example 13 [WO2009109743]   Click here for help

GtoPdb Ligand ID: 9077

Compound class: Synthetic organic
Comment: This is one of the fatty acid amide hydrolase 1 (FAAH) inhibitor compounds claimed in patent WO2009109743 [2]. FAAH inhibitors are being investigated for their potential analgesic action.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 80.24
Molecular weight 347.14
XLogP 2.67
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(N1CC(C1)Oc1ccc(cn1)c1ccccc1)Nc1cccnn1
Isomeric SMILES O=C(N1CC(C1)Oc1ccc(cn1)c1ccccc1)Nc1cccnn1
InChI InChI=1S/C19H17N5O2/c25-19(22-17-7-4-10-21-23-17)24-12-16(13-24)26-18-9-8-15(11-20-18)14-5-2-1-3-6-14/h1-11,16H,12-13H2,(H,22,23,25)
InChI Key VSQUREFTKYDATG-UHFFFAOYSA-N
References
1. Pawsey S, Wood M, Browne H, Donaldson K, Christie M, Warrington S. (2016)
Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers.
Drugs R D, 16 (2): 181-91. [PMID:26987975]
2. Roughley S, Walls S, Hart T, Parsons R, Brough P, Graham C, Macias A. (2009)
Azetidine derivatives.
Patent number: WO2009109743 A1. Assignee: Vernalis (R&D) Ltd.. Priority date: 04/03/2008. Publication date: 11/09/2009.